Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya is a research paper published in Frontiers in Reproductive Health (2023). On theSindex it has a DataRank of 0.425. It has been cited 7 times, with 7 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0.113
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 7 citers.
Eastern Virginia Medical School
Grant: AID-OAA-A-14-00010, AID-OAA-A-14-00011
NIH HHS
Grant: P51 OD011092
National Institutes of Health
Grant: 1U01PS005183-01
Evaluation of an intravaginal ring for HIV and pregnancy prevention with scientific partnerships and robust systems to strengthen HIV research in Western Kenya
National Institutes of Health
Grant: 3P51OD011092-55S1
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
United States Agency for International Development
FWCI
1.16
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals